Home 2023

MilliporeSigma

Top 10 Contract Development and Manufacturing Organizations
A-Lists

Top 10 Contract Development and Manufacturing Organizations

Alex Philippidis -
0
Viral Filtration Most Impeded During Intermediate Operating Conditions
Bioprocessing

Viral Filtration Most Impeded During Intermediate Operating Conditions

John Sterling -
0
MilliporeSigma Invests $25M to Expand Cell Culture Media Production in Kansas
Bioprocessing

MilliporeSigma Invests $25M to Expand Cell Culture Media Production in Kansas

John Sterling -
0
MilliporeSigma Grows Global Capacity to Serve Biomanufacturers
Bioprocessing

MilliporeSigma Grows Global Capacity to Serve Biomanufacturers

John Sterling -
1
MilliporeSigma Invests €35 Million in Biosafety Testing at Scotland Sites
Bioprocessing

MilliporeSigma Invests €35 Million in Biosafety Testing at Scotland Sites

John Sterling -
0
Improving Protein Therapeutic Production is a Key Goal of Biopharma 4.0
Bioprocessing

Improving Protein Therapeutic Production is a Key Goal of Biopharma 4.0

Melinda Kucsera -
20
Biomanufacturing’s 10-Year Plan for the Future
GENcast

Biomanufacturing’s 10-Year Plan for the Future

Melinda Kucsera -
21
Navigating the Regulatory Terrain during Cell & Gene Therapy Production
GENcast

Navigating the Regulatory Terrain during Cell & Gene Therapy Production

Melinda Kucsera -
17
Solve Your Biotherapeutic Challenges with Help from Gene Therapy University
GENcast

Solve Your Biotherapeutic Challenges with Help from Gene Therapy University

Melinda Kucsera -
0
Engineered Therapy: Ramping Up CAR-T Biomanufacturing Goals
GENcast

Engineered Therapy: Ramping Up CAR-T Biomanufacturing Goals

Melinda Kucsera -
20
123Page 1 of 3
Copyright © 2023 Genetic Engineering & Biotechnology News. All Rights Reserved.